Zepbound 15 mg (Tirzepatide): Side Effects, Dosage and Cost
Medically reviewed by Lauren Okafor | MD, The Frank H Netter MD School of Medicine, Loyola University Medical Center on August 31st, 2026.
Published on March 12th, 2026.
Key Takeaways
The most common side effects of Zepbound are nausea, diarrhea, vomiting and constipation. They often ease within days or weeks of each dose increase.
Zepbound (tirzepatide) is a GIP and GLP-1 receptor agonist. It's approved for chronic weight management in adults with obesity, or overweight with a weight-related health condition. It's also approved for moderate-to-severe obstructive sleep apnea in adults with obesity.
15 mg is the highest dose: a once-weekly injection under the skin, reached after at least 20 weeks of dose increases.
There is no FDA-approved generic tirzepatide. Compounded versions are not generics.
Serious side effects are rare but may include pancreatitis, gallbladder problems and thyroid concerns.
Always discuss Zepbound with your doctor before starting, especially if you have a personal or family history of thyroid cancer or multiple endocrine neoplasia.
Zepbound Side Effects (Including at 15 mg)
Most people tolerate Zepbound well, especially after the first few weeks. Side effects tend to be gastrointestinal and are most likely in the weeks after starting or increasing the dose. For more, see 7 common and serious Zepbound side effects.
Common Side Effects
Nausea: The most common side effect, especially early in treatment and after a dose increase. It's usually mild to moderate and improves within days or weeks. See managing Zepbound nausea for tips.
Vomiting: Less common than nausea. Often linked to eating too quickly or too much; eating slowly and in smaller portions helps.
Diarrhea: Common, especially early on. Staying hydrated and eating bland foods may ease symptoms.
Constipation: Common, especially early on. High fiber intake, water, and gentle movement help manage this side effect.
Abdominal pain or discomfort: Mild to moderate cramping happens in some people, especially with dose increases.
Decreased appetite: While intended, some people experience loss of appetite beyond their target, requiring attention to nutrition.
Serious Side Effects
Pancreatitis: Rare but serious inflammation of the pancreas, marked by severe upper belly pain that may spread to the back, with or without vomiting. Call 911 or get emergency care.
Gallbladder problems: Rapid weight loss can increase gallstone risk. Symptoms include upper right abdominal pain, fever, or jaundice.
Thyroid cancer or C-cell tumors: Observed in animal studies at high doses. Patients with personal or family thyroid cancer history should not use Zepbound.
Kidney problems: In rare cases, severe dehydration from vomiting or diarrhea may affect kidney function, particularly in those with pre-existing kidney disease.
Severe allergic reactions: Though uncommon, rash, swelling of the lips or throat, or trouble breathing mean you should call 911 or get emergency care.
When to Seek Medical Attention
Contact your doctor if you have persistent vomiting, belly pain that doesn't go away, yellowing skin or eyes, or a mild allergic reaction such as a rash. If you notice unusual changes in appetite, severe dehydration, or inability to keep food or fluids down for more than a few hours, reach out to your doctor promptly.
Call 911 or get emergency care for chest pain, trouble breathing, fainting, or severe belly pain that spreads to your back. See your doctor promptly if you notice a lump or swelling in your neck. Serious side effects are uncommon, and early medical attention can prevent complications.
Zepbound Side Effect Rates by Dose
How often the most common side effects happened in Zepbound's weight-loss trials (up to 72 weeks), by weekly dose.
Side effect |
5 mg |
10 mg |
15 mg |
Placebo |
|---|---|---|---|---|
Nausea |
25% |
29% |
28% |
8% |
Diarrhea |
19% |
21% |
23% |
8% |
Vomiting |
8% |
11% |
13% |
2% |
Constipation |
17% |
14% |
11% |
5% |
Source: Zepbound prescribing information, Studies 1 and 2 (5, 10 and 15 mg vs placebo).
What Zepbound Is and How It Works
Zepbound is a prescription medication that works by mimicking two natural hormones in your body: GLP-1 and GIP. These hormones help regulate appetite, blood sugar, and how your body processes food. By activating receptors for both hormones, Zepbound helps you feel fuller longer and reduces hunger signals in your brain. This dual action makes it highly effective for weight loss compared to single-hormone medications.
The FDA has approved it for chronic weight management in adults with obesity (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) with at least one weight-related health condition like type 2 diabetes, high blood pressure, or heart disease. It's also approved for moderate-to-severe obstructive sleep apnea in adults with obesity. SURMOUNT-1 is the main weight trial on its label. Over 72 weeks, adults without diabetes lost 15.0%, 19.5% and 20.9% of their body weight on average on 5, 10 and 15 mg. People on placebo lost 3.1%. Everyone also followed diet and exercise advice. Read more in what to know about tirzepatide for weight loss.
Zepbound comes as single-dose pens, single-dose vials and a KwikPen, injected once a week. There is no FDA-approved generic tirzepatide; compounded versions are not generics. This information is educational and does not replace advice from your doctor.
Zepbound Dosage Chart: Getting to 15 mg
Zepbound starts at 2.5 mg and goes up by 2.5 mg after at least 4 weeks on the current dose. The maintenance dose is 5, 10 or 15 mg once weekly, depending on response and tolerance.
Dose Level |
Form |
Frequency |
Key Detail |
|---|---|---|---|
Starting dose |
2.5 mg injection |
Once weekly |
Weeks 1 to 4; a starting dose, not a treatment dose |
2nd dose |
5 mg injection |
Once weekly |
Maintenance option; at least 4 weeks before any increase |
3rd dose |
7.5 mg injection |
Once weekly |
At least 4 weeks before any increase |
4th dose |
10 mg injection |
Once weekly |
Maintenance option; at least 4 weeks before any increase |
5th dose |
12.5 mg injection |
Once weekly |
At least 4 weeks before any increase |
Maximum dose |
15 mg injection |
Once weekly |
Highest dose and a maintenance option; reached after at least 20 weeks |
For a week-by-week schedule, see our full guide with the Zepbound dosage chart.
Drug Interactions
Zepbound may interact with other medications, particularly those affecting blood sugar, kidney function, or gastrointestinal motility. Tell your doctor about all medications, supplements and over-the-counter drugs you take.
Other GLP-1 Receptor Agonists
Taking Zepbound with other GLP-1 medications like semaglutide (Ozempic, Wegovy) or dulaglutide (Trulicity) increases the risk of severe side effects and overdose. These drugs should never be combined.
Insulin or Sulfonylureas
Zepbound lowers blood sugar, so combining it with insulin or sulfonylureas (like glyburide) may cause dangerously low blood sugar (hypoglycemia). Your doctor may need to reduce doses of these diabetes medications.
Medications That Slow Digestion
Drugs like anticholinergics or certain pain medications can slow stomach emptying, and Zepbound already slows digestion. This combination may increase gastrointestinal side effects and reduce medication effectiveness.
Thyroid Medications
If you take levothyroxine or other thyroid hormone replacements, Zepbound may affect how well these medications are absorbed. Your doctor may need to monitor thyroid function more closely and adjust doses.
Oral Contraceptives (Birth Control Pills)
Zepbound may slow the absorption of birth control pills, potentially reducing their effectiveness. If you take the pill, switch to a non-oral method or add a barrier method (such as condoms) for 4 weeks after you start Zepbound and for 4 weeks after each dose increase. Zepbound and birth control covers this in detail.
Diuretics (Water Pills)
Combined use may increase dehydration risk, particularly if vomiting or diarrhea occurs. Your doctor should monitor kidney function and electrolytes regularly.
Zepbound Cost and Generic Status
Self-pay Zepbound costs $299 to $449 a month, depending on dose (2026 prices). Lilly, the maker, sells vials and the KwikPen through LillyDirect; check there for the current price. The list price before insurance is much higher. For other ways to pay, see Zepbound without insurance.
Compounded tirzepatide is not a generic and not FDA-approved. The tirzepatide shortage ended in December 2024, so compounded copies are no longer allowed under the shortage exception. Generic vs. brand tirzepatide explains the difference.
From July 1, 2026 through December 31, 2027, the Medicare GLP-1 Bridge gives eligible Part D enrollees the Zepbound KwikPen for $50 a month (not Zepbound single-dose vials or pens). You need a BMI of 35 or higher, or 30 or higher with qualifying conditions, and prior authorization.
Pros and Cons
Pros
Highly effective for weight loss: In its main trial, people on 15 mg lost the most weight, about a fifth of their body weight on average over 72 weeks.
Once-weekly injection: Easy to remember and administer; no daily pills needed.
Improves metabolic markers: Blood sugar and blood pressure often improve with weight loss. Cholesterol changes in the trials were exploratory, not proven benefits.
Self-pay option: Lilly sells Zepbound vials and the KwikPen for self-pay from $299 a month at the lowest dose.
Well-tolerated over time: Most side effects improve after the first few weeks as your body adjusts.
Cons
Gastrointestinal side effects: Nausea, vomiting, and diarrhea are common early on and may be severe for some people.
High list price: The list price is over $1,000 a month before insurance; self-pay vials and the KwikPen cost less (see Zepbound Cost and Generic Status).
Thyroid cancer warning: The FDA warning about medullary thyroid carcinoma requires careful screening before use.
Weight regain possible: Stopping the medication often leads to gradual weight regain if diet and exercise aren't maintained.
Requires ongoing injections: Some people may dislike self-injections or develop injection site reactions.
Frequently Asked Questions
Get answers to common questions about Zepbound.
Most people begin to notice weight loss within 2 to 4 weeks of starting Zepbound, though the first few weeks may feel slower. Significant results typically appear after 8 to 12 weeks as your dose increases and your body adapts. Maximum weight loss often occurs around 52 weeks of treatment, though some continue losing weight for over a year.
You may discuss stopping Zepbound with your doctor once you reach your goal, but weight regain is common if diet and exercise habits don't stay consistent. Many people require ongoing treatment to maintain their weight loss. Never stop suddenly without medical guidance.
Only a little, for some side effects. In the label's trials, nausea was about as common at 15 mg as at 10 mg, vomiting and diarrhea were slightly more common, and constipation was less common (see the side effect rates table). Side effects are most likely in the weeks after a dose increase, so the step up to 15 mg can bring a short return of nausea.
No. There is no FDA-approved generic tirzepatide. Zepbound and Mounjaro are the only FDA-approved tirzepatide products; compounded tirzepatide is not generic and not FDA-approved, and the FDA has warned sellers that call it the same as Zepbound. Self-pay Zepbound vials and the KwikPen start at $299 a month at the lowest dose; check LillyDirect for the current price.
Eat smaller meals more slowly, avoid greasy or heavy foods, and stay hydrated with water or electrolyte drinks. Nausea usually improves within days or weeks. If vomiting persists for more than a few hours, prevents you from eating or drinking, or is severe, contact your doctor immediately, as this may indicate a more serious problem or require dose adjustment.
Yes, it can make birth control pills less effective. Switch to a non-oral method or add a barrier method for 4 weeks after you start and for 4 weeks after each dose increase. Zepbound and birth control explains why.
Still have questions?
A licensed doctor can answer questions about your own situation.
More on Zepbound
Related articles you might find helpful
Get Weight Management Support Today
Ask Doctronic your questions about Zepbound and weight management, and see a licensed doctor by video when you want one.
The Bottom Line
Zepbound 15 mg is the highest dose of a once-weekly injection that activates two hormone receptors that control hunger and blood sugar. It's approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. Stomach side effects like nausea and diarrhea are common early on and usually ease. Serious side effects are rare but need screening, especially for thyroid cancer risk. For more, see how tirzepatide and Zepbound compare and Zepbound long-term side effects. If you're weighing Zepbound, a licensed doctor can evaluate you online.
Get Support With Doctronic Now
I want to chatQuestions about Zepbound?
Chat Now